Citations 2
Efficacy and Safety of Nintedanib in Elderly Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs)
Moua, Teng , Wuyts, W.A., Miede, Corinna, Lievens, D., investigators, on behalf of the INBUILD trial, Bonella, Francesco , Okamoto, Masaki , Tomassetti, Sara , Valenzuela, Claudia , Bendstrup, Elisabeth
B22. EMERGING MANAGEMENT OF FIBROTIC ILDs | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A2426-A2426
Effects of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) Taking Anti-Acid Therapy
Kreuter, Michael , Glazer, Craig S., Kitamura, Hitoshi, Koschel, D., Moua, Teng , Röhr, Klaus, Brown, KK, investigators, on behalf of the INBUILD trial, Koschel, Dirk, Müller, H., Stowasser, Susanne , Rohr, K.B.
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD | May 4, 2021 | Volume: No volume available | Issue: No issue available | Pages: A1906-A1906